Serum Albumin Levels on Admission Are Associated With Angiographic No-Reflow After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction

Basit Öğe Kaydı
dc.authoridYarlioglues, Mikail/0000-0001-8905-9807;
dc.contributor.authorKurtul, Alparslan
dc.contributor.authorOcek, Adil Hakan
dc.contributor.authorMurat, Sani Namik
dc.contributor.authorYarlioglues, Mikail
dc.contributor.authorDemircelik, Muhammed Bora
dc.contributor.authorDuran, Mustafa
dc.contributor.authorErgun, Gokhan
dc.date.accessioned2025-10-24T18:09:29Z
dc.date.available2025-10-24T18:09:29Z
dc.date.issued2015
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractLow serum albumin (SA) levels are associated with increased cardiovascular mortality. We investigated whether baseline SA levels are associated with no-reflow following primary percutaneous coronary intervention (pPCI). A total of 536 patients (aged 60 +/- 13 years; 74% men) who underwent pPCI were enrolled. The patients were divided into 2 groups: no-reflow and normal-reflow. No-reflow was defined as thrombolysis in myocardial infarction 2 flow. Admission SA levels were significantly lower in the no-reflow group than in the normal-reflow group (3.55 +/- 0.44 vs 4.01 +/- 0.32 mg/dL, P < .001). Also, high-sensitivity C-reactive protein (hsCRP), creatinine, creatine kinase myocardial band isoenzyme, and troponin T were significantly higher while hemoglobin and left ventricular ejection fraction (LVEF) were significantly lower in the no-reflow group. In multivariate analysis, SA level remained an independent predictor of angiographic no-reflow (odds ratio 0.114, 95% confidence interval 0.032-0.405, P = .001) together with LVEF, hsCRP, and baseline culprit artery patency. Admission SA level was an independent predictor of no-reflow after pPCI.
dc.identifier.doi10.1177/0003319714526035
dc.identifier.endpage285
dc.identifier.issn0003-3197
dc.identifier.issn1940-1574
dc.identifier.issue3
dc.identifier.pmid24650948
dc.identifier.scopus2-s2.0-84925581875
dc.identifier.scopusqualityQ2
dc.identifier.startpage278
dc.identifier.urihttps://doi.org/10.1177/0003319714526035
dc.identifier.urihttps://hdl.handle.net/20.500.12899/3674
dc.identifier.volume66
dc.identifier.wosWOS:000349321200014
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherSage Publications Inc
dc.relation.ispartofAngiology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20251023
dc.subjectserum albumin level; no-reflow phenomenon; primary percutaneous coronary intervention; acute myocardial infarction
dc.titleSerum Albumin Levels on Admission Are Associated With Angiographic No-Reflow After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction
dc.title.alternativeSerum albumin levels on admission are associated with angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu